Skip to content

Clinical trials

Completed Diabetic Retinopathy trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetic Retinopathy Status: Completed Country / region: China Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20112
20131
20151
20172
20181
20193
20202
20211
20223
20233

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sun Yat-sen University5
Bayer2
Chengdu University of Traditional Chinese Medicine2
Zhongshan Ophthalmic Center, Sun Yat-sen University2
Guangdong Provincial People's Hospital1
Harbin Medical University1
Joint Shantou International Eye Center of Shantou University and the Chinese University of Hong Kong1
Ningbo Eye Hospital1
Novartis Pharmaceuticals1
Peking Union Medical College Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetic Retinopathy21
Diabetes Mellitus3
Retinal Diseases3
Retinal Vein Occlusion3
Glaucoma2
Macular Edema2
Cataract1
Central Serous Chorioretinopathy1
Conjunctivitis1
Diabetes Complications1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.